Sequential development of antibodies to specific Sm polypeptides in a patient with systemic lupus erythematosus: evidence for independent regulation of anti-double-stranded DNA and anti-Sm antibody production.

We describe a patient with systemic lupus erythematosus who, after a disease flare, sequentially produced antibodies to specific Sm polypeptides (demonstrated by counterimmunoelectrophoresis, immunoblotting, and RNA immunoprecipitation) concomitantly with the disappearance of anti-double-stranded DNA antibodies. Immunoblotting studies revealed that antibodies to the D polypeptide appeared first, followed by antibodies to BB' and E polypeptides, respectively. Our findings suggest that antibodies to the Sm-specific polypeptides do not occur simultaneously and that the regulation of their production is independent of that of antibodies to double-stranded DNA.

[1]  A. Steinberg,et al.  Systemic autoimmune disease arises from polyclonal B cell activation , 1987, The Journal of experimental medicine.

[2]  I. Pettersson,et al.  The use of immunoblotting and immunoprecipitation of (U) small nuclear ribonucleoproteins in the analysis of sera of patients with mixed connective tissue disease and systemic lupus erythematosus. A cross-sectional, longitudinal study. , 1986, Arthritis and rheumatism.

[3]  D. Fisher,et al.  Temporal shifts from Sm to ribonucleoprotein reactivity in systemic lupus erythematosus. , 1985, Arthritis and rheumatism.

[4]  T. Mimori,et al.  Detection of antibodies to small nuclear ribonucleoproteins and small cytoplasmic ribonucleoproteins using unlabeled cell extracts. , 1985, Arthritis and rheumatism.

[5]  P. Billings,et al.  A murine monoclonal antibody recognizes the 13,000 molecular weight polypeptide of the Sm small nuclear ribonucleoprotein complex. , 1985, Journal of immunology.

[6]  R. Lührmann,et al.  Autoantibodies to ribonucleoprotein particles containing U2 small nuclear RNA. , 1985, The EMBO journal.

[7]  H. Kunkel,et al.  Autoimmune sera reactive with Sm antigen contain high levels of RNP-like antibodies. , 1985, The Journal of clinical investigation.

[8]  P. Limburg,et al.  B cell activity in systemic lupus erythematosus: depressed in vivo humoral immune response to a primary antigen (haemocyanin) and increased in vitro spontaneous immunoglobulin synthesis. , 1983, Clinical and experimental immunology.

[9]  J F Fries,et al.  The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.

[10]  D. Pisetsky,et al.  Independent expression of autoantibodies in systemic lupus erythematosus. , 1982, The Journal of rheumatology.

[11]  E. Tan,et al.  Autoantibodies to nuclear antigens (ANA): their immunobiology and medicine. , 1982, Advances in immunology.

[12]  B. S. Andrews,et al.  Antibodies to Sm in patients with systemic lupus erythematosus. Correlation of Sm antibody titers with disease activity and other laboratory parameters. , 1981, Arthritis and rheumatism.

[13]  J. Steitz,et al.  Monoclonal antibodies to nucleic acid-containing cellular constituents: probes for molecular biology and autoimmune disease. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[14]  D. Pisetsky,et al.  Mechanisms of autoantibody production in autoimmune MRL mice , 1980, The Journal of experimental medicine.

[15]  J. Steitz,et al.  Antibodies to small nuclear RNAs complexed with proteins are produced by patients with systemic lupus erythematosus. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[16]  L. Aarden,et al.  Anti-dsDNA and complement profiles as prognostic guides in systemic lupus erythematosus. , 1979, Arthritis and rheumatism.

[17]  B. Doft,et al.  Increased spontaneous activity of antibody-forming cells in the peripheral blood of patients with active SLE. , 1977, Arthritis and rheumatism.

[18]  E. Tan,et al.  Identification of antibodies to nuclear acidic antigens by counterimmunoelectrophoresis. , 1976, Arthritis and rheumatism.